Medindia

X

Reportlinker Adds Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Wednesday, December 16, 2009 Cancer News J E 4
Advertisement


NEW YORK, Dec. 15 Reportlinker.com announces that a new market research report is available in its catalogue:

Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

http://www.reportlinker.com/p0167294/Colorectal-Cancer---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016.html

Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Summary

GlobalData, the industry analysis specialist's new report, "Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global colorectal cancer market. The report identifies the key trends shaping and driving the global colorectal cancer market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global colorectal cancer sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope

The scope of the report includes:

- Annualized global colorectal cancer market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.

- Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.

- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.

- Analysis of the current and future market competition in the global colorectal cancer market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with colorectal cancer.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global colorectal cancer market.

- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global colorectal cancer market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global colorectal cancer market landscape? - Identify, understand and capitalize.

Table of Contents

1 Colorectal Cancer Market: Executive Summary

2 Table of Contents

2.1 List of Tables

2.2 List of Figures

3 Colorectal Cancer Market: Market Characterization

3.1 Overview

3.2 Colorectal Cancer Market Size

3.3 Colorectal Cancer Market Forecast and CAGR

3.4 Drivers and Barriers for Colorectal Cancer Market

3.4.1 Drivers for Colorectal Cancer Market

3.4.2 Barriers for Colorectal Cancer Market

3.5 Opportunity and Unmet Need

3.6 Key Takeaway

4 Colorectal Cancer Market: Competitive Assessment

4.1 Overview

4.2 Strategic Competitor Assessment

4.3 Product Profiles of the Major Marketed Products

4.3.1 Overview

4.3.2 Efficacy

4.3.3 Safety Profile

4.3.4 Pricing

4.3.5 Clinical Study Details

4.4 Key Takeaway

5 Colorectal Cancer Market: Pipeline Assessment

5.1 Overview

5.2 Strategic Pipeline Assessment

5.2.1 Technology Trends Analytical Framework

5.3 Colorectal Cancer Therapeutics - Promising Drugs under Clinical Development

5.4 Molecule Profiles of Promising Drugs under Clinical Development

5.4.1. Overview

5.4.2 Efficacy

5.4.3 Safety

5.4.4 Clinical Study Details

5.5 Colorectal Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action

5.6 Colorectal Cancer Pipeline - Pipeline by Clinical Phases of Development

5.6.1 Colorectal Cancer Therapeutics - Phase III Clinical Pipeline

5.6.2 Colorectal Cancer Therapeutics - Phase II Clinical Pipeline

5.6.3 Colorectal Cancer Therapeutics - Phase I Clinical Pipeline

5.6.4 Colorectal Cancer Therapeutics - Preclinical Pipeline

5.6.5 Colorectal Cancer Therapeutics - Discovery Pipeline

5.7 Discontinued / Suspended Drugs for Colorectal Cancer

5.8 Key Takeaway

6 Colorectal Cancer Market: Implications for Future Market Competition

7 Colorectal Cancer Market: Future Players in Colorectal Cancer Market

8 Colorectal Cancer Market: Appendix

8.1 Definitions

8.2 Acronyms

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasting

8.3.3.1 Epidemiology-based Forecasting

8.3.4 Primary Research

8.3.5 Expert Panel validation

8.4 Contact Us

8.5 Disclaimer

8.6 Sources

List of Tables

Table 1: Global Colorectal Cancer Treatment by Stage of the Disease, 2009

Table 2: Global Colorectal Cancer Therapeutics Market, Revenue Forecasts ($ m), 2001-2009

Table 3: Global Colorectal Cancer Therapeutics Market, Revenue Forecasts ($ m), 2009-2016

Table 4: Major marketed products comparison in Colorectal Cancer, 2009

Table 5: Colorectal Cancer Therapeutics - Most Promising Drugs Under Clinical Development, 2009

Table 6: Colorectal Cancer Therapeutics - Phase III Clinical Pipeline, 2009

Table 7: Colorectal Cancer Therapeutics - Phase II Clinical Pipeline, 2009

Table 8: Colorectal Cancer Therapeutics - Phase I Clinical Pipeline, 2009

Table 9: Colorectal Cancer Therapeutics - Preclinical Pipeline, 2009

Table 10: Colorectal Cancer Therapeutics - Drug Discovery Pipeline, 2009

Table 11: Colorectal Cancer Therapeutics - List of Discontinued Drugs, 2009

List of Figures

Figure 1: Global Colorectal Cancer Therapeutics Market Forecast, 2000-2015

Figure 2: Colorectal Cancer Therapeutics Market - Opportunity and Unmet Need, 2009

Figure 3: Colorectal Cancer Therapeutics Market - Strategic Competitor Assessment, 2009

Figure 4: Technology Trends Analytic Framework of the Colorectal Cancer Pipeline, 2009

Figure 5: Technology Trends Analytic Framework of the Colorectal Cancer Pipeline - Description, 2009

Figure 6: Colorectal Cancer Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2009

Figure 7: Colorectal Cancer Pipeline by Phase of Clinical Development, 2009

Figure 8: Colorectal Cancer Therapeutics Market - Strategic Competitor Assessment, 2009

Figure 9: Colorectal Cancer Therapeutics Market - Clinical Pipeline by Company, 2009

Figure 10: GlobalData Methodology

Figure 11: GlobalData Market Forecasting Model

To order this report:

Pharmaceutical Industry: Colorectal Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

More Market Research Report

Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Reportlinker Adds Bladder Cancer - Drug Pipeline A...
S
Infosys Reiterates its Commitment in LATAM With Ph...